Sage Journals: Discover world-class research

Open access

Research article

First published 2021

Prophylactic Anticoagulation With Intermediate-Dose Certoparin in Vascular-Risk Pregnancies—The PACER-VARP Registry

Martin Grünewald, Esther Häge, Stephanie Lehnert [...]

Clinical and Applied Thrombosis/Hemostasis

Retricted access

Research article

First published 1982-11

Disposition of Intermediate-Dose Methotrexate in Children with Acute Lymphocytic Leukemia

William E. Evans, Clinton F. Stewart, Paul R. Hutson [...]

Annals of Pharmacotherapy

Free access

Research article

First published 2012-7

Regulatory Forum Opinion Piece: Obligatory Microscopic Examination of Intermediate Dose Groups in Non-Rodent Toxicity Studies—Is It Necessary?

Diann L. Weddle, Charles R. Mahrt, Stephen P. Schmidt

Toxicologic Pathology

Open access

Research article

First published 2018-10

The Efficacy and Safety of Intermittent Low-Dose Urokinase Thrombolysis for the Treatment of Senile Acute Intermediate-High-Risk Pulmonary Embolism: A Pilot Trial

Tianming Zhao, Jixiang Ni, Xuehua Hu [...]

Clinical and Applied Thrombosis/Hemostasis

Retricted access

Research article

First published 2022-12

Safety and feasibility of outpatient high-dose cytarabine and intermediate-dose cytarabine for consolidation therapy in acute myeloid leukemia

Wenhui Li, Katherine Richter, Jamie Lee [...]

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2021-10

Comparing High and Low-Dose Radio-Iodine Therapy in Thyroid Remnant Ablation Among Intermediate and Low-Risk Papillary Thyroid Carcinoma Patients—Single Centre Experience

Tahira Yasmin, Sadia Adnan, Muhammad Numair Younis [...]

Dose-Response

Free access

Research article

First published 2024-2

Comparison of Standard Versus Intermediate Prophylaxis Dose for Venous Thromboembolism Prophylaxis in Patients Hospitalized With COVID-19 Infection

Munyaradzi Stanley Chakabva, Sarah Polina, Mckenna Brauner [...]

Hospital Pharmacy

Open access

Research article

First published 2017

Nonmonotonic Pathway Gene Expression Analysis Reveals Oncogenic Role of p27/Kip1 at Intermediate Dose

Hien H Nguyen, Susan C Tilton, Christopher J Kemp [...]

Cancer Informatics

Free access

Research article

First published 2020-12

Toxicologic Pathology Forum: Opinion on Obligatory Microscopic Examination of Intermediate-Dose Groups in Toxicity Studies With Biotherapeutics in Cynomolgus Monkeys

Cecilia Parrula, Zuhal Dincer, Frank J. Geoly [...]

Toxicologic Pathology

Retricted access

Research article

First published 2025-1

Low-Dose Valganciclovir Prophylaxis Against Cytomegalovirus in Intermediate-Risk Liver and Dual-Abdominal Transplant Recipients

Yihan Li, Dawn M. Pluckrose, Roshani Patolia [...]

Annals of Pharmacotherapy

Search results